Vibeke Hatorp
- Co-authors
- Mikael S. ThomsenKristian T. HansenPaul RolanSøren Erik LarsenLisbeth Bjerring JensenMilan ZdravkovićJeppe SturisHenrik Agersø
- Topics
- Diabetes Treatment and Management (13 papers)Pharmacology and Obesity Treatment (7 papers)Pharmacogenetics and Drug Metabolism (4 papers)
- Journals
- The Journal of Clinical Endocrinology & MetabolismDiabetes CareClinical Pharmacology & Therapeutics
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Vibeke Hatorp
14 papers receiving 716 citations
Peers
Comparison fields: 5 of 62
- Endocrinology, Diabetes and Metabolism 510
- Molecular Biology 239
- Surgery 194
- Pharmacology 193
- Oncology 182
Countries citing papers authored by Vibeke Hatorp
This map shows the geographic impact of Vibeke Hatorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vibeke Hatorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vibeke Hatorp more than expected).
Fields of papers citing papers by Vibeke Hatorp
This network shows the impact of papers produced by Vibeke Hatorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vibeke Hatorp. The network helps show where Vibeke Hatorp may publish in the future.
Co-authorship network of co-authors of Vibeke Hatorp
This figure shows the co-authorship network connecting the top 25 collaborators of Vibeke Hatorp. A scholar is included among the top collaborators of Vibeke Hatorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vibeke Hatorp. Vibeke Hatorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 11 | |
| 3 | 75 | |
| 4 | 118 | |
| 5 | 237 | |
| 6 | 66 | |
| 7 | 13 | |
| 8 | 38 | |
| 9 | 17 | |
| 10 | 50 | |
| 11 | 66 | |
| 12 | 2 | |
| 13 | 29 | |
| 14 | 1 | |
| 15 | Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers. | 57 |
About Vibeke Hatorp
Vibeke Hatorp is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Pharmacology, having authored 15 papers that have together received 780 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (13 papers), Pharmacology and Obesity Treatment (7 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (510 citations), Pharmacology (193 citations) and Pharmacology (140 citations). Vibeke Hatorp has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Mikael S. Thomsen, Kristian T. Hansen, Paul Rolan, Søren Erik Larsen, Lisbeth Bjerring Jensen, Milan Zdravković, Jeppe Sturis, Henrik Agersø, Grethe Jakobsen and Poul Strange. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.